Imbed Biosciences
Company profile
Primary focus
Development and manufacture of fully synthetic, bioresorbable polymer wound matrices with sustained antimicrobial activity.
Why it’s included
The company develops and manufactures fully synthetic, bioresorbable antimicrobial wound matrices designed to conform to wound beds and provide sustained broad-spectrum antimicrobial activity, with FDA 510(k) clearances and DoD-funded R&D specifically for prevention of wound infections in acute and surgical wounds, directly matching the topic's requirements.
Relevant capabilities
- Integration of broad-spectrum antimicrobial agent into polymer matrix
- In vitro antimicrobial efficacy testing and microbiological assays
- Design and fabrication of ultra-thin bioresorbable polymer matrices for wound application
- Biocompatibility and preclinical safety testing (ISO 10993 and animal studies)
- Clinical evidence generation and case-series/poster study support
Commercial sectorAntimicrobial Wound Dressings & Matrices
Technology classesSilver-based antimicrobial dressings and coatings, Conformable wound fillers for cavity antimicrobial delivery
Relevant commercial products
- Synthetic antimicrobial wound matrix (bioresorbable polymer)
- SAMatrix
- DualGuard™ Silver-Gallium Matrix
- Microlyte® Ag/Lidocaine
- Surgaflex PainGuard
Relevant patents
1 family, 5 publications- Methods and compositions for wound healing US-12409247-B2